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Abstract
Background: Surfactant protein-A (SP-A) has been shown to play a variety of roles related to lung host defense 
function. Mice lacking SP-A are more susceptible to infection than wild type C57BL/6 mice. We studied 
bronchoalveolar lavage (BAL) protein expression in wild type and SP-A-/- mice infected with Klebsiella pneumoniae by 
2D-DIGE.
Methods: Mice were infected intratracheally with K. pneumoniae and after 4 and 24 hours they were subject to BAL. 
Cell-free BAL was analyzed by 2D-DIGE on two-dimensional gels with pH ranges of 4-7 and 7-11. Under baseline 
conditions and at 4 and 24 hr post-infection BAL was compared between untreated and infected wild type and SP-A-/
- mice. Sixty proteins identified by mass spectrometry were categorized as host defense, redox regulation, and protein 
metabolism/modification.
Results: We found: 1) ~75% of 32 host defense proteins were lower in uninfected SP-A-/- vs wild type, suggesting 
increased susceptibility to infection or oxidative injury; 2) At 4 hr post-infection > 2/3 of identified proteins were higher 
in SP-A-/- than wild type mice, almost the exact opposite of untreated mice; 3) At 24 hr post-infection some proteins 
continued increasing, but many returned to baseline; 4) In infected wild type mice significant changes occurred in 13 
of 60 proteins, with 12 of 13 increasing, vs on 4 significant changes in SP-A-/- mice. Infection response patterns 
between strains demonstrated both commonalities and differences. In several cases changes between 4 and 24 hr 
followed different patterns between strains.
Conclusions: These indicate that SP-A plays a key role in regulating the BAL proteome, functioning indirectly to 
regulate lung host defense function, possibly via the macrophage. In the absence of SP-A baseline levels of many host 
defense molecules are lower. However, many of these indirect deficits in SP-A-/- mice are rapidly compensated for 
during infection, indicating that SP-A also has a direct role on host defense against K. pneumoniae that may be 
instrumental in determining clinical course.
Introduction
Pulmonary surfactant is a lipoprotein complex essential
for normal lung function. The protein component of pul-
monary surfactant consists of hydrophobic and hydro-
philic proteins including surfactant protein A (SP-A). SP-
A has been shown to play a crucial role in innate immune
function in the lung. Among the reported functions of
SP-A in this regard are: enhancing the clearance of patho-
gens by acting as an opsonin [1,2], regulating the produc-
tion of cell surface antigens and inflammatory mediator
expression by immune cells [3,4], participating in the
development of dendritic cells [5], regulating reactive oxi-
dant production [6,7], and others [1,8]. Mice lacking SP-A
have been shown to have increased susceptibility to a
variety of infectious agents [9-11] and were found to have
increased mortality after infection with Klebsiella pneu-
moniae as compared to wild-type mice [12]. The mecha-
nism(s) by which SP-A exerts these effects are not well
understood. In some cases the observed function appears
to be directly attributable to SP-A via its well-docu-
mented ability to enhance phagocytosis of some patho-
gens [1,2], but because SP-A can regulate expression of
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Page 2 of 18various regulatory molecules, including some cytokines,
it is also likely that at least some of these functions are
indirect effects of SP-A. Comparing the bronchoalveolar
lavages (BAL) from C57BL/6 wild type (WT) and SP-A-/-
mice on the same genetic background [13] demonstrated
that SP-A had the ability to influence a diverse collection
of proteins and also demonstrated an exaggerated
response to oxidative stress (following an acute ozone
exposure) in SP-A-/- mice, suggesting altered regulation
in the absence of SP-A.
K. pneumoniae, a gram-negative bacteria and a mem-
ber of the Enterobacteriaceae family has long been recog-
nized as a possible cause of community-acquired
pneumonia in individuals with impaired pulmonary
defenses [14]. We [12,15] and others [16,17] have
employed a mouse model of K. pneumoniae pneumonia
to study the mechanisms responsible for host defense
against this pathogen and the implications of infection.
These studies have demonstrated increased severity
when infection follows an acute oxidative stress, as a con-
sequence of hyperoxia or ozone exposure [12,15,16]. Fur-
thermore, reports of increased susceptibility to K.
pneumoniae infection in mice lacking SP-A [12],
lysozyme [18], and β 2-microglobulin [19] indicate that
the host defense against this pathogen may be multifacto-
rial.
In order to explore the impact of K. pneumoniae infec-
tion on the BAL proteome in WT and SP-A-/- mice we
employed two-dimensional difference gel electrophore-
sis (2D-DIGE), an unbiased discovery proteomics tech-
nique [20-22] for quantitation of proteins, coupled with
Matrix Assisted Laser Desorption Ionization-Time-of-
Flight/Time-of-Flight (MALDI-ToF/ToF) tandem mass
spectrometry for identification of proteins. Using these
techniques we can simultaneously analyze large numbers
of proteins in the BAL. Two-dimensional gel-based tech-
niques, including 2D-DIGE, have been used to study the
BAL proteome in lung disease [23-25] and in various
experimental systems [13,26-29]. These techniques may
also have the potential to implicate pathways that may
not have been previously suspected to play a role in these
systems. We recently employed a similar approach to
examine age-related changes in the rat BAL proteome
[29] and to characterize ozone-induced changes in the
mouse BAL proteome [13]. As in our previous studies
[13,29] we used the PANTHER database and the pub-
lished literature to assign many of the proteins identified
to three major categories: host defense function (DEF);
redox regulation (RED); and protein metabolism and
modification (PMM).
The rationale for the present study is based on the two
following hypotheses: 1) The absence of SP-A compro-
mises host defense against K. pneumoniae increasing sus-
ceptibility to infection and the severity of disease. 2) SP-A
influences the levels of expression of other proteins with
host defense function, thereby predisposing SP-A-/- mice
to infection. To test these hypotheses we investigated dif-
ferences in BAL protein expression between C57BL/6
WT and SP-A-/- mice before infection and in response to
K. pneumoniae infection with a discovery proteomics
approach. Simultaneous analyses of dozens of proteins
and their isoforms in biological samples can help in the
identification of pathways and proteins involved in the
host response to K. pneumoniae infection. The type of
unbiased approach used in this study does not depend on
previously published studies and may be instrumental in
generating specific novel hypotheses involving proteins
and pathways that may not have been previously impli-
cated in the processes being studied.
In this study we compared the BAL proteomes of
untreated WT and SP-A-/- mice infected with K. pneu-
moniae for 4 and 24 hr and studied the resulting changes
in the BAL proteome using 2D-DIGE, coupled with
MALDI-ToF/ToF for protein identification.
Materials and methods
Animals
This study was conducted with pathogen-free male WT
and SP-A-/- male mice on the C57BL/6 genetic back-
ground. WT mice were obtained from Jackson Laborato-
ries (Bar Harbor, ME) and housed under standard
environmental conditions prior to the experiment.
Breeder pairs of SP-A-/- mice were obtained from Dr.
Samuel Hawgood at the University of California, San
Francisco and were bred and raised under specific patho-
gen-free conditions in a barrier facility at the Penn State
College of Medicine. The SP-A-/- mice and sentinel mice
housed in the same room showed no evidence of respira-
tory pathogens. The Institutional Animal Care and Use
Committee at the Penn State College of Medicine
approved this study.
A total of 24, 11-12 week old (20-25 g) C57BL/6 WT
and SP-A-/- mice were used in the present study. These
were divided into six groups with 4 animals per group: 1)
WT control that did not receive any treatment; 2) WT
exposed to K. pneumoniae for 4 hr; 3) WT exposed to K.
pneumoniae for 24 hr; 4) SP-A-/- control that did not
receive any treatment; 5) SP-A-/- exposed to K. pneumo-
niae for 4 hr; 6) SP-A-/- exposed to K. pneumoniae for 24
hr.
Bacteria
K. pneumoniae bacteria (ATCC 43816) were obtained
from the American Tissue Culture Collection (Rockville,
MD). Bacteria were inoculated into 50 ml of tryptic soy
broth (TSB) in 250 ml flasks for 18 hr at 37°C (stationary
phase), with shaking at 120 rpm (Incubator Series 25,
New Brunswick Scientific Co., Edison, NJ). The bacterial
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and then 200 μl of this diluted bacterial suspension was
added to 50 ml of TSB for 3 hr to reach mid-log phase of
growth (OD660 ~0.4, corresponding to ~2 × 108 CFU/ml),
where bacteria are most virulent. Bacteria were placed on
ice to stop their growth and then serially diluted in PBS to
obtain ~9 × 103 CFU/ml. For infection, 50 μl of this sus-
pension (~450 CFU/mouse) were used as in our previous
studies [12,15].
Infection of mice with K. pneumoniae
Animals were anesthetized with an intramuscular injec-
tion of a mixture of Ketamine HCl (Ketaject, Phoenix
Pharmaceuticals Inc., St. Joseph, MO) and Xylazine
(XYLA-JECT, Phoenix Pharmaceuticals Inc., St. Joseph,
MO). The trachea was surgically exposed and ~450 CFU/
mouse were inoculated intratracheally in 50 μl of PBS.
Skin incisions were closed with 7 mm wound clips. Mice
infected in this way are not in apparent respiratory dis-
tress and mortality during the first 48 hours is rare. As
described in our previous studies, the dose administered
was an LD50 for WT male mice in survival studies, with
most mortality occurring between 3 and 5 days [15].
BAL fluid
The lungs of the anesthetized mice were subjected to
BAL at intervals of 4 and 24 hr following infection. BAL
fluid was obtained by instilling saline into the lungs
through a tracheal cannula using a volume equal to 80%
of lung vital capacity (3 × with 0.5 ml of 0.9% NaCl) for a
total of 1.5 ml. Total BAL fluid recovery was approxi-
mately 90% of the instilled volume and did not differ sig-
nificantly between the experimental groups and controls.
The BAL fluid was centrifuged (150 × g, 10 min, 4°C) and
cell-free supernatant was frozen at -80°C for subsequent
proteomic studies.
BAL protein assessment
Protein concentrations were determined using the Bio-
Rad Protein Assay (Bio-Rad, Hercules, CA) before and
after protein precipitation. For precipitation one volume
of ice cold 100% TCA was added to four volumes of pro-
tein sample, which were mixed and incubated overnight
at 4°C. Following overnight incubation, samples were
centrifuged (15,000 × g, 15 min, 4°C) and the protein pel-
lets washed with 250 μl of chilled acetone (-20°C), centri-
fuged again, resuspended in a minimum volume of
standard cell lysis buffer (30 mM Tris HCl, 2 M thiourea,
7 M urea, 4% CHAPS, 8.5). The concentration of protein
was brought to 1 mg/ml for CyDye labeling.
One-dimensional gel electrophoresis
Protein (12.5 μg) from each sample was subjected to gel
electrophoresis using ExcelGel 12.5% SDS-PAGE separat-
ing gels with a 5% stacking gel. Gels were run at 20 mA
for 30 min and then for 1 hour at 50 mA and then silver
stained (SilverQuest™ Silver Staining Kit, Invitrogen,
Carlsbad, CA).
Protein identification from one-dimensional gel 
electrophoresis
Bands of interest were excised from 1D-gels after silver
staining and processed for MALDI-ToF/ToF mass spec-
trometry (4800 Proteomic Analyzer Applied Biosystems,
Foster City, CA) as described below.
2D-DIGE labeling (minimal labeling) and electrophoresis 
for 2D-DIGE
Information about the 2D-DIGE study is provided in a
form that complies with the most recent version. http://
www.psidev.info/miape/MIAPE_GE_1_4.pdf of Mini-
mum Information About a Proteomics Experiment-Gel
Electrophoresis (MIAPE-GE) standards currently under
development by the Human Proteome Organization Pro-
teomics Standards Initiative (see Additional File 1). Two
sets of samples from each group were prepared for mini-
mal labeling with CyDyes. Samples from each group were
randomly assigned to Cy3 or Cy5 to ensure no dye-based
artifacts in quantitation. A 25 μg aliquot of BAL protein
from each sample was labeled with either Cy3 or Cy5 (200
picomoles). A normalization pool was created by com-
bining equal amounts of protein from every sample (24
samples) and an aliquot of the pool was labeled with Cy2
(200 picomoles/25 μg). Equal amounts (25 μg) of Cy3-
labeled sample, Cy5-labeled sample, and Cy2-labeled
pool samples were mixed and applied to each gel. The use
of a normalization pool is advantageous as this serves as
an internal standardization tool for all gels/samples under
study, and thus normalizes any quantitative differences
due to gel-to-gel variability. An equal volume of 2 × sam-
ple buffer (2 M thiourea, 7 M urea, 2% IPG buffer (pH 4-7
or pH 7-11 nonlinear (NL)) and 1.2% DeStreak reagent)
was added to all samples to give a final volume of 150 μl.
The 24 cm pH 4-7 and pH 7-11NL gradient Immobiline
DryStrips (GE Healthcare) were rehydrated for 16 hr with
450 μl of rehydration buffer (DeStreak™ Rehydration
Solution containing 0.5% IPG buffer (pH 4-7 or pH 7-11).
Proteins were subjected to isoelectric focusing on rehy-
drated strips using the Ettan IPGphor 3 cup loading man-
ifold (GE Healthcare) following manufacturer's
instruction at 20°C and under mineral oil to prevent
evaporation. Proteins were focused by using the following
voltages and times: 3 hr at 300 V (step and hold); 7 hr at
1000 V (gradient); 4 hr at 8000 V (gradient); 4 hr at 8000
V (step and hold). After isoelectric focusing the IEF strips
were equilibrated in equilibration solution-1 (50 mM Tris
HCl, 6 M urea, 30% glycerol, 2% sodium dodecyl sulphate
(SDS), 0.5% dithiothreitol) and equilibration solution-2
Ali et al. Proteome Science 2010, 8:34
http://www.proteomesci.com/content/8/1/34
Page 4 of 18(50 mM Tris HCl, 6 M urea, 30% glycerol, 2% SDS, 4.5%
iodoacetamide) for 15 min, respectively, and then applied
to 10-14% gradient polyacrylamide gels (26 cm-w × 20
cm-h × 1 mm thick), sealed with 0.5% low melting point
agarose containing bromophenol blue in a buffer of 1 ×
Tris/glycine/SDS buffer (25 mM Tris, 192 mM glycine,
0.1% (W/V) SDS, pH 8.3) and run for 30 min at 5 W/gel
and then for 6-7 hr at 14 W/gel at 20°C using the Ettan
DALTtwelve system (GE Healthcare) for separation of
proteins on the basis of molecular weight.
For preparative (picking) gels an aliquot of 350 μg of
sample was diluted with an equal volume of 2 × sample
buffer (2 M thiourea, 7 M urea, 2% IPG buffer (pH 4-7 or
pH 7-11) and 1.2% DeStreak reagent) and then brought
up to a volume of 450 μl with rehydration buffer
(DeStreak™ Rehydration Solution and 0.5% IPG buffer
(pH 4-7 or pH 7-11)). Proteins were focused using the fol-
lowing voltages and times: 14 hr at 0 V (passive rehydra-
tion); 6 hr at 30 V (active rehydration); 3 hr at 300 V (step
and hold); 3 hr at 600 V (gradient); 3 hr at 1000 V (gradi-
ent); 3 hr at 8000 V (gradient); 4 hr at 8000 V (step and
hold). Each of the strips was equilibrated as described
above and applied to a 10-14% gradient polyacrylamide
gels (26 cm-w × 20 cm-h × 1 mm thick). For the prepara-
tive picking gel a single plate for each gel plate sandwich
was treated with Bind-Silane solution (80% ethanol,
0.02% glacial acetic acid, 0.001% Bind-Silane) and had ref-
erence marker stickers placed on them. After the comple-
tion of electrophoresis, the plates that had not been
silane-treated were removed from the sandwich and the
gels were fixed overnight with 30% ethanol, 7.5% glacial
acetic acid. The preparative picking gels were then
stained with Deep Purple Total Protein Stain (GE,
Healthcare) for 2 hr.
Gel scanning, image analysis, and statistics
Information about the acquisition and processing of data
from the 2D-DIGE studies are provided in the form that
complies with the most recent version of the guidelines
established for Minimum Information about a Proteom-
ics Experiment - Gel Informatics (MIAPE-GI) currently
under development by the Human Proteome Organiza-
tion Proteomics Standards Initiative. http://www.
psidev.info/files/miape-gi-v1.pdf (see Additional File 2).
All two-dimensional gels were imaged on a Typhoon
9400 fluorescent imager (GE Healthcare) at a resolution
of 100 μm. Photomultiplier tube voltages were individu-
ally set for each of the three colored lasers to ensure max-
imum, linear signals. The same voltages were used for all
the gels. The DIGE gels were imaged at three different
wavelengths (Cy2: 520 nm; Cy3: 580 nm; Cy5: 670 nm)
and the Deep Purple Total Protein Stain-stained gels were
imaged at 100 μm with a separate filter (610 nm).
Gel images were imported into the Progenesis SameS-
pots v2.0 program (Nonlinear Dynamics) for analysis and
their quality assessed by the program. Image quality con-
trol with Progenesis SameSpots v2.0 involves checking
images for bit depth, color, manipulation prior to analy-
sis, proper file type, saturation, low dynamic range, and
stretched contrast. A reference gel with minimum distor-
tion and streaks was selected from the Cy 2 gels. Gel
alignment was conducted automatically and then
checked manually to ensure correct alignment. Spot
detection and spot matching across all the gels were con-
ducted automatically, and then spot matching was
checked and manually edited to ensure correct matching.
Data from all the spots included in analysis were trans-
ported to Progenesis PG240 module of the Progenesis
SameSpots v2.0 software for further analysis. Statistical
analysis was performed by t-test to confirm the level of
significance among various groups.
For identified proteins having multiple isoforms, the
normalized volumes of all isoforms of a given protein
were added together and statistical analysis was per-
formed on the totals using Microsoft Excel.
Protein identification by mass spectrometry
For identification of spots, protein spots were picked
from picking gels using a robot-directed spot picker
(Ettan Spot Picker, GE Healthcare). The spots selected for
picking were determined on the basis of differential
expression from the 2D-DIGE analyses. The picker head
was calibrated using the reference stickers placed on the
preparative picking gel and the gels were picked and gel
plugs placed in a bar-coded 96 well plate. All gel plugs
were washed twice with 200 μl of 200 mM ammonium
bicarbonate, 40% acetonitrile for 30 min at 37°C and
dehydrated one time with 75% acetonitrile for 20 min fol-
lowed by air drying. The protein was then digested with
20 μl of 0.02 μg/μl trypsin (Trypsin, proteomics grade,
Sigma, St. Louis, MO) overnight at 37°C. Fifty μl 50% ace-
tonitrile, 0.1% trifluoroacetic acid (TFA), was next added
to each plug and incubated for 30 min at 37°C. Digested
proteins/peptides were then transferred to 96-well
extraction plates, dried by speed vac (Vaccufuge™ Con-
centrator, Eppendorf AG, Hamburg, Germany) and
resuspended in 10 μl 0.5% TFA. Extracted proteins/pep-
tides were desalted and concentrated using C18 ZipTips
(Millipore Corporation, Billerica, MA). Tips were wetted
with 10 μl of 100% acetonitrile and equilibrated with 10 μl
0.1% TFA pH < 4. Samples were then drawn into ZipTip
columns by aspirating for 7 cycles and then washed twice
with 10 μl 0.1% TFA. Peptides were then eluted from the
column with 5 μl of 50% acetonitrile, 0.1% TFA.
Peptides were then analyzed by MALDI-ToF/ToF mass
spectrometry (4800 Proteomic Analyzer Applied Biosys-
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the Penn State University College of Medicine. A total of
3 μl of ZipTip cleaned samples (1 μl at a time) was applied
onto a 384-well MALDI plate (Opti-TOF™ 384 Well
Insert, Applied Biosystems) and then 0.7 μl of 2 mg/ml
ACH cinnamic acid in 60:40 (acetonitrile: water) was
then spotted on each well containing peptide. All 13-cali-
bration wells on the MALDI plate were spotted with (1:12
diluted) 4700 calibrant. Autolytic trypsin peptides were
also used to internally calibrate the spectra to an accuracy
of 20 ppm. Using the GPS Explorer 3.0.software (Applied
Biosystems), the MS and MS/MS data were submitted to
the MASCOT search engine using the NCBI non-redun-
dant and SwissProt databases and mouse taxonomy for
identification. MASCOT confidence interval scores of >
95% were considered as positive protein identification.
The PANTHER database and the scientific literature
were used to assign molecular function and biological
process to each identified protein. We assigned the iden-
tified proteins to several broad functional classes includ-
ing: a) host defense proteins (DEF); b) proteins involved
in regulating redox balance (RED); and c) proteins
involved in protein metabolism and modification (PMM).
It should be noted that some proteins are in more than
one functional group. This classification scheme, which
we have used in other studies [13,29] was more inclusive
than relying solely on the biological function classifica-
tion provided by PANTHER and similar gene ontology
databases. We also used the Ingenuity Pathway Analysis
program (Ingenuity Systems, Redwood City, CA) to gain
additional insight into the functional significance of the
observed changes.
Results and Discussion
We investigated the hypothesis that SP-A plays a role in
the host defense of mouse lungs at baseline conditions
and following infection with K. pneumoniae. Towards
this goal we used one-dimensional gels and 2D-DIGE to
compare the BAL proteomes of C57BL/6 mice and SP-A-
/- mice on the same genetic background under baseline
conditions. We then characterized changes in the BAL
proteome at 4 and 24 hr after intratracheal infection with
K. pneumoniae and compared the responses between the
two strains of mice in order to gain insight into molecules
and pathways involved in the presence and absence of SP-
A.
1-D gel analysis of BAL proteins from K. pneumoniae-
infected WT and SP-A-/- mice
Although there were no significant differences among
groups in the amount of fluid recovered by BAL, signifi-
cant (p < 0.05) increases in total protein concentration
were observed in infected (4 hr and 24 hr) WT and SP-A-
/- mice when compared with the corresponding
untreated mice (Figure 1). However, there were no signif-
icant differences in total BAL protein between WT and
SP-A-/- mice under any of the experimental conditions. It
should be noted that this increase, based on the results
that will be described subsequently, does not appear to be
due to increased permeability and an influx of serum pro-
teins into the alveolar space. This is evident from the fact
that abundant serum proteins (i.e. albumin, ceruloplas-
min, haptoglobin, prothrombin, etc.) are not increasing in
proportion to the changes in total protein concentration.
One-dimensional gel analysis (data not shown) revealed
a band of potential interest at ~14 kDa which appeared
with higher intensity in SP-A-/- control mice compared
to WT control mice. However, as infection progressed,
the intensity of the 14 kDa band decreased in the SP-A-/-
mice and increased in the WT mice, indicating that this
14 kDa protein may play a role in host defense. MALDI-
ToF/ToF mass spectrometry analysis of the 14 kDa pro-
tein band identified it as lysozyme, a protein known to
have antibacterial properties [18,30].
2D-DIGE analysis
To provide the broadest proteomic coverage, two differ-
ent pH gradients were used in the first dimension gels.
One employed a pH 4-7 gradient and the other used a pH
7-11 gradient. We chose the pH 7-11 gradient because
the isoelectric point of lysozyme is ~pH 11 and the
lysozyme content was seen to change between SP-A-/-
and WT mice in the presence and absence of infection in
the 1-D analysis. This gradient allowed us to resolve some
of the very basic proteins, such as lysozyme, that would
not typically be resolved in pH 3-10 gels. The pH 4-7 gra-
Figure 1 BAL total protein concentration. The total protein concen-
tration of cell-free BAL fluid was determined. The total amount of fluid 
recovered during BAL (~90% of instilled volume) did not differ signifi-
cantly among groups. The histogram depicts mean protein concentra-
tion values (n = 4/group) and standard deviations are indicated by 
error bars. Values of WT mice that differ significantly (p < 0.05) from 
baseline by t-tests are indicated by an asterisk (*) and values of SP-A-/- 
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range are somewhat compressed when a pH 3-10 gradi-
ent is used. However, it is possible that there may have
been some proteins in very acidic and more basic ranges
that were not resolved. A 10-14% polyacrylamide gradi-
ent was used for the second dimension separation to
allow a better resolution of lower molecular weight pro-
teins, although the resolution of some proteins with
higher molecular weights was slightly compromised. The
2D-DIGE analysis involved 715 protein spots of which
279 spots constituting 60 proteins were visualized in all
samples and identified by MALDI-ToF/ToF (Table 1).
The identified proteins accounted for 93% of the detect-
able protein on the pH 4-7 gels (Figure 2A) and 39% on
the pH 7-11 gels (Figure 2B).
Whole BAL supernatant samples (without serum pro-
tein depletion) were used for both pH ranges. Depletion
of serum proteins results in substantial reductions in the
amount of protein available and would have precluded us
from performing the two first-dimensional separations
with different pH ranges. Below we present and compare
changes in the BAL proteome of WT and SP-A-/- mice.
We studied: 1) the levels of expression of specific proteins
under baseline conditions, 2) levels of expression at each
of two time points after infection, and 3) comparisons
between the two mouse strains, namely the patterns of
changes in expression during the course of infection.
1) Baseline conditions
This is the first time that the BAL proteome of SP-A-/-
mice has been compared to their WT counterpart under
baseline conditions. In this state the differences between
the two strains are rather striking, although the responses
to infection that will be described subsequently show
many similarities. Of the 60 proteins studied (59 when
SP-A is excluded), there were decreases in levels of
expression of more than 40 proteins, 24 of these decreas-
ing by more than 25%. Increases were seen in 19 proteins,
7 of these increasing by more than 25%. Out of all of these
changes, there were significant differences in the levels of
expression of 14 proteins, 11 of these significant changes
being decreases (Table 2).
In order to help elucidate the potential functional sig-
nificance of these changes we assigned the identified pro-
teins to several broad functional classes based on
reviewing the published studies reporting the functions
of these proteins (see Table 1). The classes were: a) host
defense proteins (DEF); b) proteins involved in regulating
redox balance (RED); and c) proteins involved in protein
metabolism and modification (PMM). It should be noted
that some proteins are in more than one functional
group. This classification scheme, which we have used in
other studies [13,29] was more inclusive than relying
solely on the biological function classification provided
by PANTHER and similar gene ontology databases.
Other authors have focused on groups of proteins
involved in host defense and oxidative stress in studies of
the BAL proteome in response to exogenous glucocorti-
coid treatment or stress [26,27]. We analyzed the changes
in these functional groups to determine whether we
could gain insight into the basis for: a) the phenotype of
the SP-A-/- mice, specifically their greater susceptibility
to infection and increased mortality due to infection [12];
and b) the tendency of SP-A-/- mice (compared to WT
mice) to experience an aggravated response to oxidative
stress resulting from an acute ozone exposure that we
have described previously [13,31].
More than half of the identified proteins (n = 31,
excluding SP-A) were designated DEF proteins (Table 1).
Roughly 2/3 of these proteins (n = 22) were expressed at
lower levels in SP-A-/- mice than in WT animals, and 14
of these proteins showed at least a 25% reduction from
WT levels. Of the 7 DEF proteins that differed signifi-
cantly between strains, 5 of these were at lower levels in
the SP-A-/- mice and 2 were at higher levels, as was
lysozyme (although its increase did not achieve statistical
significance). SP-A was not included in these compari-
sons because of its absence in the SP-A-/- mice.
Proteins in the RED group exhibited a similar pattern.
This group consisted of 26 proteins and 16 of them were
at decreased levels in the SP-A-/- mice, with 12 of the 16
proteins showing at least a 25% reduction. Six of the 9
RED proteins differing significantly between strains were
decreased in SP-A-/- mice. A similar trend was also noted
in PMM proteins (n = 13) where 9 of the proteins showed
reduced levels of expression in the SP-A-/- mice.
Notable among the decreased proteins in the SP-A-/-
mice were annexins A1 and A5, apolipoprotein A-1, sev-
eral complement components, several glutathione trans-
ferases, and peroxiredoxin 6. These proteins have all been
attributed protective roles against infection, inflamma-
tion, and reactive oxidants, and their decreased levels in
the SP-A-/- mice, together with the absence of SP-A, sug-
gest that these mice could be vulnerable to a wide range
of insults. SP-A-/- mice exhibit increased susceptibility to
infection, reduced survival, reduced macrophage activa-
tion, inability to combat infection, and an exaggerated
response to oxidative stress [9,10,12,31-33]. However,
there are also some indications of possible compensatory
measures to counter the host defense deficits resulting
from the lack of SP-A. Lysozyme and β-2-microglobulin,
both of which serve in pathogen defense in mice [18,19]
were elevated in the SP-A-/- mice under baseline condi-
tions.
One could argue, based on the predominance of pro-
teins exhibiting reduced levels of expression in the SP-A-/
- mice, that there was a non-specific reduction in the pro-
duction and secretion of BAL proteins in this group.
However, this possibility is refuted by the fact that the
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Page 7 of 18Table 1: List of identified proteins
Gel No. Protein Accession No. Functional Group IPG
1 14-3-3-Zeta P63101 DEF, RED, PMM 4-7
2 Adipsin (Complement factor D) P03953 DEF, PMM 4-7
3 Albumin P07724 RED 4-7
4 Aldehyde dehydrogenase AHD-M1 P47738 RED 4-7
5 Aldehyde dehydrogenase II P24549 RED 7-11
6 Aldehyde dehydrogenase, Dimeric NADP-preferring (EC 1.2.1.5) 
(ALDH class 3)
P47739 RED 4-7
7 Alpha-1-antitrypsin 1-1 precursor (Serine protease inhibitor 1-1) P07758 DEF, PMM 4-7
8 Alpha-1-antitrypsin 1-6 precursor (Serine protease inhibitor 1-6) 
(Alpha-1 protease inhibitor)
P81105 DEF, PMM 4-7
9 Alpha-fetoprotein P02772 4-7
10 Annexin A1 (Annexin I) (Lipocortin I) (Calpactin II) (Chromobindin-9) 
(P35)
P10107 DEF 4-7
11 Annexin A3 O35639 4-7
12 Annexin A4 Q3UCL0 4-7
13 Annexin A5 P48036 DEF 4-7
14 Apolipoprotein A-1 Q58EV2 DEF, RED 4-7
15 Beta-2-microglobulin Q91XJ8 DEF 7-11
16 Beta-actin P60709 4-7
17 Beta-actin (putative, AA 27-375) (alpha-actin) Q61275 4-7
18 Carbonyl reductase 2 P08074 RED 7-11
19 Cell specific 10K protein (uteroglobin - mouse) (Clara cell 10K protein) 
(CC10) (CC16)
Q06318 DEF, RED 7-11
20 Ceruloplasmin isoforms Q61147 RED 4-7
21 Chain A, The Crystal structure of novel mammalian lectin Ym1-
suggests a saccharide binding site
O35744 DEF 4-7
22 Chain B, Chimeric human mouse carbonmonoxyhemoglobin (Human 
zeta, Mouse beta 2)
P02088 7-11
23 Chia protein Q91XA9 DEF 4-7
24 Coiled-coil domain containing 122 Q8BVN0 4-7
25 Complement component 3 Q80XP1 DEF 4-7
26 Complement component C5 P06684 DEF 4-7
27 Contrapsin (Serine protease inhibitor A3K) P07759 PMM 4-7
28 Creatine kinase M-type (EC.2.7.3.2) (Creatine kinase M chain) (M-CK) P07310 4-7
29 Cytosolic malate dehydrogenase P14152 RED 4-7
30 (Similar to) Ferritin light chain 1 (Ferritin L, subunit 1) P29391 DEF, RED 4-7
31 Gamma-actin P63260 4-7
32 Gelsolin precursor (Actin-depolymerizing factor) (ADF) (Brevin) P13020 DEF, RED, PMM 4-7
33 Glutathione S-transferase, alpha 3 P30115 DEF, RED 7-11
34 Glutathione S-transferase, alpha 4 P24472 DEF, RED 4-7
35 Glutathione S-transferase, mu 1 P10649 DEF, RED 7-11
36 Glutathione S-transferase, omega 1 O09131 DEF, RED 4-7
37 (Similar to) Glutathione S-transferase, Ya chain (GST class-alpha) (Ya1) P13745 DEF, RED 4-7
38 Haptoglobin Q60574 DEF, RED 4-7
39 Hemoglobin subunit alpha (Hemoglobin alpha chain)(Alpha-globin) P01942 7-11
40 Isocitrate dehydrogenase [NADP] cytoplasmic (EC 1.1.1.42) (Cytosolic 
NADP-Isocitr)
O88844 RED 4-7
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Page 8 of 18protein content of BAL from both strains does not differ
significantly (Figure 1) and there are a number of proteins
whose levels of expression are higher in SP-A-/- mice.
However, the fact that many DEF and RED proteins are
reduced in the SP-A-/- mice under baseline conditions is
consistent with prior reports that the alveolar mac-
rophages of SP-A-/- mice are dysfunctional or hypoactive
[12]. This finding leads us to speculate that the absence of
SP-A results in reduced levels of regulatory molecules
produced by these macrophages that may be responsible
for these lower levels of expression of DEF and RED pro-
teins.
2) Responses to K. pneumoniae infection
We compared the proteins expressed by WT and SP-A-/-
mice at each of the two time points following infection
(Table 2), as well as the pattern of changes in protein
expression between time points in each strain (Tables 3
and 4).
a) Strain differences at 4 hr after infection As com-
pared to uninfected animals, we observed a very different
picture when we compared strains following infection
with K. pneumoniae. Four hr after infection the levels of
more than two-thirds (n = 40) of the identified BAL pro-
teins in SP-A-/- mice were increased as compared to WT
mice. The proteins found to be increased in SP-A-/- mice
after infection (Table 2) included many of the proteins
that had been found to be decreased under baseline con-
ditions in uninfected SP-A-/- mice as compared to WT
mice. Our working hypotheses to explain these differ-
ences are: a) that expression of these proteins is stimu-
lated by the induction of infection, probably as a
consequence of increased levels of regulatory molecules
such as cytokines; b) in order to compensate for the lower
baseline levels of many proteins in SP-A-/- mice, expres-
sion of these proteins is strongly stimulated or overcom-
pensated with infection in SP-A-/- mice; and c) the
absence, or deficit, of some (as yet unidentified) regula-
tory molecules in the SP-A-/- mice (as postulated above)
results in a poorly regulated, overexuberant response to
infection so that levels of expression after infection often
exceed those seen in WT mice. It is also of interest to
note that several of the proteins (13 proteins out of 59)
that were present in increased amounts in the uninfected
SP-A-/- mice respond to infection by reducing their levels
41 Keratin complex 1, acidic, gene 10 P02535 7-11
42 (Similar to) Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) 
(Keratin-10)
A2A513 4-7
43 Kpnb1 protein b Q99KM9 4-7
44 Lactate dehydrogenase 2, B chain P16125 DEF, RED 4-7
45 Lysozyme 2 P08905 DEF, RED 7-11
46 Murinoglobulin-1 precursor (MuG1) P28665 DEF, PMM 4-7
47 Myosin heavy chain IIB Q9JHR4 7-11
48 Peroxiredoxin 1 P35700 RED 7-11
49 Peroxiredoxin 6 Q6GT24 DEF, RED 4-7
50 Pregnancy zone protein Q61838 DEF, PMM 4-7
51 Prothrombin precursor (Ec 3.4.21.5) (Coagulation factor II) P19221 DEF, PMM 4-7
52 Pulmonary surfactant associated protein A precursor (SP-A) (PSP-A) 
(PSAP)
P35242 DEF, RED 4-7
53 Rho GDP dissociation inhibitor (GDI) alpha Q99PT1 4-7
54 SEC14-like 3 Q5SQ27 PMM 4-7
55 Selenium binding protein 1 P17563 DEF, RED 4-7
56 Selenium binding protein 2 Q63836 DEF, RED 4-7
57 Serine (or cysteine) proteinase inhibitor, clade A, member 1e Q00898 PMM 4-7
58 Toll-like receptor 13 precursor Q6R5N8 DEF 4-7
59 Transferrin Q921I1 DEF, RED, PMM 4-7
60 Tyrosine-3-monooxygenase/tryptophan 5-monooxynase activation 
protein, Epsilon polypeptide
Q8BPH1 PMM 4-7
Proteins identified by 2D-DIGE. Gel numbers (see Fig. 2), protein names, SwissProt accession numbers, functional groups and pH gradients 
(IPG) of the gel where the proteins were identified are listed. Abbreviations for functional groups: DEF, host defense; PMM, protein 
modification and metabolism; RED, redox regulation.
Table 1: List of identified proteins (Continued)
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Page 9 of 18below those seen in the corresponding infected WT mice,
resulting in a regulatory pattern that is almost the inverse
of that described above for most of the proteins. These
proteins decreased in infected SP-A-/- mice include both
lysozyme and β2-microglobulin. A number of the proteins
mentioned above are included in the categories of posi-
tive and negative acute phase proteins and the patterns of
expression we describe are consistent with this classifica-
tion.
Together, the observations made and the hypotheses
stated earlier indicate that in the absence of SP-A there is
a loss of regulatory control to appropriately modulate
expression of DEF proteins in response to infection. Con-
sistent with this postulate, a recent study with SP-A-/-
mice demonstrated that in response to low level intrapha-
ryngeal LPS treatment (0.5 ng), significantly higher levels
of MIP-2 were observed compared to the untreated con-
trol [34]. However, in this study similarly treated WT
mice did not have increases in MIP-2 at low LPS doses,
but required a higher LPS concentration to exhibit a sim-
ilar increase [34]. Interestingly, a recent study in which
LPS was administered into a lobe of healthy volunteers'
lung found significant decreases in levels of SP-A [28].
Unfortunately, there was little overlap in the sets of iden-
tified proteins between our studies and therefore little
basis for comparison.
When the DEF and RED proteins are individually
examined as subgroups of the identified proteins, the
changes are similar to those noted for all proteins. In both
of these groups of proteins, more proteins show increased
levels of expression in infected SP-A-/- mice vs infected
WT mice (18 DEF proteins; n = 17 RED proteins), a situa-
tion that is almost the exact opposite of what was seen in
untreated mice and consistent with the loss of regulatory
control we propose in the SP-A-/- mice.
It is not yet known what causes these rapid changes.
They may result from the presence of bacteria, the influx
of immune cells to combat the bacteria, or the release of
mediator(s) from immune cells or epithelium to deal with
the insult. We speculate that the rapidity of the response
(within 4 hr) is due to the release of stored mediators,
such as chemokines, rather than due to the synthesis and
secretion of new protein. As stated earlier, because many
of the identified proteins were at lower levels in the
untreated SP-A-/- mice, the post-infection response may
be an effort to restore these proteins to levels that can
reduce the threat posed by the instilled bacteria. Two
proteins that may play important roles in host defense
and have been shown to contribute specifically to host
defense against K. pneumoniae, lysozyme and β-2-micro-
globulin, were of particular interest [18,19]. These pro-
teins exhibited higher levels in the untreated SP-A-/-
mice, perhaps in an effort to bolster the compromised
host defense status of these mice, but following infection
their levels in the SP-A-/- mice dropped to below those
seen in WT mice. A consistent finding was observed for
lysozyme by 1-D gel analysis (data not shown). Whether
this reduction in the levels of these proteins was a conse-
quence of their involvement and elimination in the course
of defense processes against the instilled bacteria or a
reduction in their synthesis remains to be determined.
b) Strain differences at 24 hr after infection Extending
the analysis to mice infected 24 hr earlier we gained some
additional insight into the response pattern. Three gen-
Figure 2 Reference gels. The reference gels for two-dimensional separations in pH 4-7 gels (A) and pH 7-11 gels (B) are shown. Protein spots that 
have been identified by MALDI-ToF/ToF are circled and numbered and all proteins are named in Table 1. Note that in cases where multiple isoforms 
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Page 10 of 18Table 2: Changes in protein expression between wild-type and SP-A-/- mice for control, 4 hr post infection and 24 hr post 
infection: percent changes with significance for all identified proteins corresponding to reference gels in Fig. 2
Gel No. Protein Functional Group % Δ WT
to SP-A-/-
Baseline





1 14-3-3-Zeta DEF, RED, PMM -34.97 16.24 -10.69
2 Adipsin (Complement factor D) DEF, PMM -63.51 5.95 4.76
3 Albumin RED 4.82 1.56 12.73
4 Aldehyde dehydrogenase AHD-M1 RED -82.62 37.46 29.21
5 Aldehyde dehydrogenase II RED 135.85 14.63 31.75
6 Aldehyde dehydrogenase, Dimeric 
NADP-preferring (EC 1.2.1.5) (ALDH class 3)
RED 58.04 40.10 38.77
7 Alpha-1-antitrypsin 1-1 precursor (Serine 
protease inhibitor 1-1)
DEF, PMM -30.98 15.12 16.63
8 Alpha-1-antitrypsin 1-6 precursor (Serine 
protease inhibitor 1-6) (Alpha-1 protease 
inhibitor)
DEF, PMM -12.72 -9.38 -12.84
9 Alpha-fetoprotein -16.1 24.43 -11.61
10 Annexin A1 (Annexin I) (Lipocortin I) 
(Calpactin II) (Chromobindin-9) (P35)
DEF -201.08 72.45 4.89
11 Annexin A3 21.76 -7.73 1.22
12 Annexin A4 13.78 14.08 3.38
13 Annexin A5 DEF -381.16 -66.73 -130.01
14 Apolipoprotein A-1 DEF, RED -23.3 -89.53 93.80
15 Beta-2-microglobulin DEF 68.18 -59.79 -55.69
16 Beta-actin -14.27 32.95 13.93
17 Beta-actin (putative, AA 27-375) 
(alpha-actin)
4.84 52.39 9.19
18 Carbonyl reductase 2 RED -184.18 29.93 0.81
19 Cell specific 10K protein (uteroglobin - 
mouse) (Clara cell 10K protein) (CC10) 
(CC16)
DEF, RED -73.76 12.90 64.31
20 Ceruloplasmin isoforms RED 22.02 -9.13 -19.71
21 Chain A, Crystal structure of novel 
mammalian lectin Ym1-suggests a 
saccharide binding site
DEF -2.98 28.89 13.35
22 Chain B, Chimeric human mouse 
carbonmonoxyhemoglobin (Human zeta, 
Mouse beta 2)
-5.61 8.67 33.51
23 Chia protein DEF 5.35 31.40 17.25
24 Coiled-coil domain containing 122 -183.85 21.31 -6.43
25 Complement component 3 DEF -12.5 40.66 8.39
26 Complement component C5 DEF -22.76 21.75 5.19
27 Contrapsin (Serine protease inhibitor A3K) PMM 7.77 -8.52 -8.74
28 Creatine kinase M-type (EC.2.7.3.2) 
(Creatine kinase M chain) (M-CK)
-57.22 28.34 -22.83
29 Cytosolic malate dehydrogenase RED -3.05 7.03 1.31
30 (Similar to) Ferritin light chain 1 (Ferritin L, 
subunit 1)
DEF, RED -87.39 -14.84 -3.35
31 Gamma-actin -20.73 31.85 20.75
32 Gelsolin precursor (Actin-depolymerizing 
factor) (ADF) (Brevin)
DEF, RED, PMM 30.02 -3.09 -2.90
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Page 11 of 18eral trends were seen. 1) In one set of proteins (n = 11)
there was little change between 4 and 24 hr. 2) In another
set (n = 36), at the 24 hr point there were proteins in
which the levels of expression tended to revert back (?- or
~-shaped response pattern) toward the levels seen under
baseline conditions, suggesting a peak response at 4 hr
(or at least earlier than 24 hr). 3) In a third set (n = 5), lev-
els of some proteins at 24 hr were continuing to either
increase or decrease from levels seen at 4 hr, suggesting
slower and/or more sustained responses to infection.
With respect to all identified proteins, the ratio of
increased to decreased proteins (34/25 = 1.36) at 24 hr is
33 Glutathione S-transferase, alpha 3 DEF, RED -193.11 21.05 19.07
34 Glutathione S-transferase, alpha 4 DEF, RED -339.42 64.33 38.47
35 Glutathione S-transferase, mu 1 DEF, RED -101.12 45.92 35.09
36 Glutathione S-transferase, omega 1 DEF, RED -132.89 48.91 15.84
37 (Similar to) Glutathione S-transferase, Ya 
chain (GST class-alpha) (Ya1)
DEF, RED -318.76 56.63 44.05
38 Haptoglobin DEF, RED -14.69 16.92 2.41
39 Hemoglobin subunit alpha (Hemoglobin 
alpha chain)(Alpha-globin)
-6.6 -32.60 132.59
40 Isocitrate dehydrogenase [NADP] 
cytoplasmic (EC 1.1.1.42) (Cytosolic 
NADP-Isocitr)
RED -21.59 17.31 1.14
41 Keratin complex 1, acidic, gene 10 16.11 20.63 -30.55
42 (Similar to) Keratin, type I cytoskeletal 10 
(Cytokeratin-10) (CK-10) (Keratin-10)
-43.31 26.68 -5.45
43 Kpnb1 protein b -55.63 53.13 34.52
44 Lactate dehydrogenase 2, B chain DEF, RED 28.46 -4.34 -3.26
45 Lysozyme 2 DEF, RED 129.29 -63.56 -133.43
46 Murinoglobulin-1 precursor (MuG1) DEF, PMM -14.21 -16.51 -6.93
47 Myosin heavy chain IIB -21.97 6.81 -15.67
48 Peroxiredoxin 1 RED -83.18 24.93 11.30
49 Peroxiredoxin 6 DEF, RED -54.85 56.63 42.36
50 Pregnancy zone protein DEF, PMM -1.56 2.46 -7.38
51 Prothrombin precursor (Ec 3.4.21.5) 
(Coagulation factor II)
DEF, PMM -59.43 6.39 5.13
52 Pulmonary surfactant associated protein A 
precursor (SP-A) (PSP-A) (PSAP)
DEF, RED ND ND ND
53 Rho GDP dissociation inhibitor (GDI) alpha -115.4 -22.62 -42.11
54 SEC14-like 3 PMM -33.59 30.46 9.92
55 Selenium binding protein 1 DEF, RED 9.26 -4.10 -3.32
56 Selenium binding protein 2 DEF, RED 27.17 -2.40 -3.86
57 Serine (or cysteine) proteinase inhibitor, 
clade A, member 1e
PMM 7.7 -18.15 -11.72
58 Toll-like receptor 13 precursor DEF 18.41 -17.04 -4.57
59 Transferrin DEF, RED, PMM 8.65 -17.12 -0.37
60 Tyrosine-3-monooxygenase/tryptophan 
5-monooxynase activation protein, Epsilon 
polypeptide
PMM -183.11 18.41 -7.70
Changes (% Δ) in BAL protein expression from wild-type (WT) to SP-A-/- mice are shown for untreated (baseline) animals, 4 hours post-
infection and 24 hours post-infection. Gel numbers (see Fig. 2), protein names, functional groups and percent change (% Δ) are listed. 
Abbreviations for functional groups: DEF, host defense; PMM, protein modification and metabolism; RED, redox regulation. Bolded numbers 
indicate changes that were significant (p < 0.05 by t-test). Values for SP-A, which is absent in SP-A-/- mice, are listed as not determined (ND).
Table 2: Changes in protein expression between wild-type and SP-A-/- mice for control, 4 hr post infection and 24 hr post 
infection: percent changes with significance for all identified proteins corresponding to reference gels in Fig. 2 (Continued)
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Page 12 of 18Table 3: List of proteins with similar changes in both strains of mice between 4 hours and 24 hours post infection
Gel No. Protein Accession No. % Δ WT % Δ SP-A-/-
1 14-3-3-Zeta P63101 35.39 5.23
2 Adipsin (Complement factor D) P03953 -3.11 -4.28
4 Aldehyde dehydrogenase AHD-M1 P47738 -0.68 -7.11
5 Aldehyde dehydrogenase II P24549 -25.89 -9.53
6 Aldehyde dehydrogenase, Dimeric NADP-preferring (EC 1.2.1.5) (ALDH 
class 3)
P47739 -4.45 -5.45
7 Alpha-1-antitrypsin 1-1 precursor (Serine protease inhibitor 1-1) P07758 11.73 13.19
8 Alpha-1-antitrypsin 1-6 precursor (Serine protease inhibitor 1-6) 
(Alpha-1 protease inhibitor)
P81105 -1.97 -5.19
9 Alpha-fetoprotein P02772 58.71 14.27
10 Annexin A1 (Annexin I) (Lipocortin I) (Calpactin II) (Chromobindin-9) 
(P35)
P10107 104.30 24.23
11 Annexin A3 O35639 -11.62 -2.36
15 Beta-2-microglobulin Q91XJ8 -11.91 -9.04
17 Beta-actin (putative, AA 27-375) (alpha-actin) Q61275 98.26 42.05
18 Carbonyl reductase 2 P08074 -14.63 -47.75
19 Cell specific 10K protein (uteroglobin - mouse) (Clara cell 10K protein) 
(CC10) (CC16)
Q06318 189.97 322.02
20 Ceruloplasmin isoforms Q61147 9.88 0.00
21 Chain A, The Crystal structure of novel mammalian lectin Ym1-suggests 
a saccharide binding site
O35744 29.60 13.98
22 Chain B, Chimeric human mouse carbonmonoxyhemoglobin (Human 
zeta, Mouse beta 2)
P02088 42.79 75.43
23 Chia protein Q91XA9 27.11 13.42
24 Coiled-coil domain containing 122 Q8BVN0 55.69 20.59
27 Contrapsin (Serine protease inhibitor A3K) P07759 8.67 8.44
28 Creatine kinase M-type (EC.2.7.3.2) (Creatine kinase M chain) (M-CK) P07310 103.29 28.96
30 (Similar to) Ferritin light chain 1 (Ferritin L, subunit 1) P29391 -32.41 -19.16
32 Gelsolin precursor (Actin-depolymerizing factor) (ADF) (Brevin) P13020 -11.18 -10.99
33 Glutathione S-transferase, alpha 3 P30115 33.97 9.01
34 Glutathione S-transferase, alpha 4 P24472 28.76 8.61
35 Glutathione S-transferase, mu 1 P10649 -3.93 -12.25
36 Glutathione S-transferase, omega 1 O09131 32.86 3.36
37 (Similar to) Glutathione S-transferase, Ya chain (GST class-alpha) (Ya1) P13745 17.64 8.19
39 Hemoglobin subunit alpha (Hemoglobin alpha chain) (Alpha-globin) P01942 47.17 353.87
41 Keratin complex 1, acidic, gene 10 P02535 125.91 43.46
43 Kpnb1 protein b Q99KM9 -0.48 -14.37
44 Lactate dehydrogenase 2, B chain P16125 -9.56 -8.43
46 Murinoglobulin-1 presursor (MuG1) P28665 -14.22 -4.83
47 Myosin heavy chain IIB Q9JHR4 59.33 28.97
48 Peroxiredoxin 1 P35700 20.27 7.45
51 Prothrombin precursor (Ec 3.4.21.5) (Coagulation factor II) P19221 8.81 7.52
52 Pulmonary surfactant associated protein A precursor (SP-A) (PSP-A) 
(PSAP)
P35242 37.49 ND
53 Rho GDP dissociation inhibitor (GDI) alpha Q99PT1 48.73 28.33
55 Selenium binding protein 1 P17563 -1.65 -0.89
56 Selenium binding protein 2 Q63836 -2.42 -3.88
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Page 13 of 18lower than at 4 hr (40/19 = 2.1), although the increases
continue to predominate. However, most of this change is
due to the PMM group, which has reverted at the 24 hr
point post-infection to having more than twice as many
proteins (9 of 13) at reduced levels in the SP-A-/- mice, as
was the case in control (baseline) SP-A-/- mice. The over-
all numbers of increased and decreased expression levels
of DEF and RED proteins at the 24 hour point are quite
similar to those seen at 4 hr after infection. However,
there were a few notable exceptions. For example, apoli-
poprotein A-1, which is known to exhibit anti-inflamma-
tory activity [35], was lower in SP-A-/- mice than WT
mice both at baseline (-23.3%) and after 4 hr of infection
(-89.53%), but by the 24 hour time point its levels were
markedly higher in the SP-A-/- mice (93.8%), indicating a
delayed response in the SP-A-/- mice.
c) Potential pathways affected by changes We also
used the Ingenuity Systems Pathways Analysis program
to better understand the functional implications of the
absence of SP-A, both under baseline conditions and
after infection with K. pneumoniae. These analyses are
depicted in Figure 3 and provide a graphic demonstration
of the trends we described from our statistical analysis.
Roughly half of the identified proteins were included in a
network with components of this network having roles in
a variety of biological processes that are relevant to our
experimental model. These include infection by bacteria,
inflammatory response, complement activation, phago-
cytosis of macrophages, and others. Proteins that were
57 Serine (or cysteine) proteinase inhibitor, clade A, member 1e Q00898 -9.83 -3.86
60 Tyrosine-3-monooxygenase/tryptophan 5-monooxynase activation 
protein, Epsilon polypeptide
Q8BPH1 33.02 4.31
Changes (% Δ) in BAL protein expression that were similar for wild-type (WT) and SP-A-/- mice between 4 and 24 hours post infection are 
shown. Gel numbers (see Fig. 2), protein names, SwissProt accession numbers and percent change (% Δ) for both WT and SP-A-/- are listed. 
Bolded numbers indicate changes that were significant (p < 0.05 by t-test) between 4 and 24 hours for a given group. Values for SP-A, which 
is absent in SP-A-/- mice are listed as not detectable (ND) in SP-A-/- mice.
Table 3: List of proteins with similar changes in both strains of mice between 4 hours and 24 hours post infection (Continued)
Table 4: List of proteins with different changes for strains of mice between 4 hours and 24 hours post infection
Gel No. Protein Accession No. % Δ WT % Δ SP-A-/-
3 Albumin P07724 -3.61 7.12
12 Annexin A4 Q3UCL0 3.05 -7.09
13 Annexin A5 P48036 23.19 -11.99
14 Apolipoprotein A-1 Q58EV2 -166.30 37.97
16 Beta-actin P60709 11.33 -4.82
25 Complement component 3 Q80XP1 5.47 -23.04
26 Complement component C5 P06684 12.19 -3.16
29 Cytosolic malate dehydrogenase P14152 2.02 -3.55
31 Gamma-actin P63260 0.67 -8.47
38 Haptoglobin Q60574 1.80 -12.16
40 Isocitrate dehydrogenase [NADP] cytoplasmic (EC 1.1.1.42) (Cytosolic NADP-Isocitr) O88844 10.70 -4.77
42 (Similar to) Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) A2A513 24.80 -7.04
45 Lysozyme 2 P08905 4.36 -36.75
49 Peroxiredoxin 6 Q6GT24 4.30 -5.42
50 Pregnancy zone protein Q61838 5.37 -4.41
54 SEC14-like 3 Q5SQ27 8.92 -8.97
58 Toll-like receptor 13 precursor Q6R5N8 -4.87 6.73
59 Transferrin Q921I1 -12.29 3.92
Changes (% Δ) in BAL protein expression that were different for wild-type (WT) and SP-A-/- mice between 4 and 24 hours post infection are 
shown. Gel numbers (see Fig. 2), protein names, SwissProt accession numbers and percent change (% Δ) for both WT and SP-A-/- are listed. 
Bolded numbers indicate changes that were significant (p < 0.05 by t-test) between 4 and 24 hours for a given group.
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Page 14 of 18not linked in the network are shown in the inset. In the
diagram reflecting baseline conditions (Fig. 3A) the
majority of proteins are colored green, reflecting levels of
expression in the SP-A-/- mice below those seen in WT
mice, as we described earlier. A very different picture is
seen when the same comparison is made at 4 hr after
infection (Fig. 4). At this time point most of the proteins
are red, representing the fact that expression is higher in
SP-A-/- mice than in WT mice and indicating that in the
SP-A-/- mice the synthesis and/or secretion of these pro-
teins is rapidly enhanced by infection.
3) Comparison of changes that occur in each strain between 4 
and 24 hr after infection
A comparison of the infection-induced response between
4 and 24 hr in WT and SP-A-/- mice, was made by calcu-
lating changes in the levels of specific proteins between 4
and 24 hr of infection in each strain, and comparing the
WT and SP-A-/- mice. This analysis showed the follow-
ing. The first difference of note is that changes between 4
and 24 hr in 13 of the 59 identified proteins were statisti-
cally significant in the WT mice, 12 of the 13 being signif-
icant increases (Tables 3 and 4). By contrast, there were
only 4 significant changes between 4 and 24 hr in the SP-
A-/- mice. However, in general the response patterns
were quite similar in both strains with 41 proteins
(excluding SP-A) showing either increases or decreases in
both strains (Table 3) and 18 more that showed increases
in one strain and decreases in the other (Table 4). The
similarities and differences between strains in the
responses are described below in more detail.
a) Similar responses in both strains Following infec-
tion of mice with K. pneumoniae there were a number of
proteins that underwent similar changes between 4 and
24 hr after infection, typically increases, in both strains of
mice (Table 3). The first group of note includes beta-
actin, myosin IIB (a non-muscle myosin), creatine kinase
M, and Rho GDP dissociation inhibitor-alpha. All of
these are proteins that play a role in phagocytosis [36]
and are increased in both strains. These increases could
be related to the presence of increased numbers of
phagocytic cells to combat the infection. In all cases the
amount of increase was greater in the WT mice and for
most of the proteins the changes attained statistical sig-
nificance only in WT mice.
Also notable were the increases in two chitinases, Ym1
and Chia protein (an acidic mammalian chitinase). The
increases were statistically significant in WT mice, but
did not achieve significance in the SP-A-/- mice. These
proteins appear to play a role in asthma, chronic obstruc-
tive pulmonary disease, and other inflammatory lung dis-
eases [37-39] although their exact action in these
conditions is not known. Annexin A1 had a similar pat-
tern, increasing with infection in both strains, but only
reaching significance in the WT mice. The basis for this
increase is unclear but its altered expression here may
play a protective role against infection. This postulate is
consistent with various reported actions of Annexin A1.
These include its protective role after organ injury [40]
that could be similar to the case with infection, and its
ability to promote apoptosis and limit cell proliferation
[41], a potentially important function in the present situ-
ation given the rapid influx of immune cells following
lung infection. Also increased was the Clara cell protein,
CC10 or CC16, which is considered to be a marker of
lung injury [42] and may have anti-inflammatory activity.
Pronounced increases in its levels of expression were
seen in both strains, but were greater in the SP-A-/- mice.
These increases appear to be a response to the lung injury
resulting from K. pneumoniae infection.
We also observed increases in alpha and beta chains of
hemoglobin in both strains. Unlike the changes described
above, the degree of change for both proteins was greater
in the SP-A-/- mice than in WT. It should be pointed out
that we did not observe corresponding increases in other
serum proteins including albumin, ceruloplasmin, and
haptoglobin indicating that these increases in hemoglo-
bin are probably not due to serum protein leakage into
the alveolar spaces. Hemoglobin expression has been
shown to occur in alveolar epithelial cells [43]. Moreover,
it has been shown that cell-free hemoglobin may play a
role in the scavenging of NO [44], the levels of which
increase in response to various stresses. Thus, the func-
tion of this hemoglobin produced in the lung may be one
of protection against nitrosative stress as postulated pre-
viously [43,44]. This protection may come about via its
ability to bind NO and thereby reduce harmful reactive
species such as peroxynitrite [43,44].
The above changes describe aspects of the response to
infection that were similar in both mouse strains,
although in many cases (30 of 42) the magnitude of these
changes was greater in the WT mice than in SP-A-/-
mice.
b) Responses that differ between strains In addition to
the list of similar responses described above, there were
changes occurring between 4 and 24 hr that followed dif-
ferent patterns (i.e. increased in WT; decreased in SP-A-/
- or vice versa Table 4). These included annexin A5, apoli-
poprotein A-1, and lysozyme. Apolipoprotein A-1 (Apo
A-1) is a known negative acute phase protein and during
infection in the WT mice its levels decreased by 166%.
Among other actions, Apo A-1 neutralizes LPS and has
anti-inflammatory activity [35,45]. The decrease in its
levels as the duration of infection increases in WT mice
(thereby lessening its anti-inflammatory influence), could
be interpreted as permitting a vigorous defense against
the infecting organism. During the same interval in the
SP-A-/- mice, levels of Apo A-1 increase by 38%. Given
the actions of Apo A-1, this increase could impede the
Ali et al. Proteome Science 2010, 8:34
http://www.proteomesci.com/content/8/1/34
Page 15 of 18response against the K. pneumoniae infection: a) by neu-
tralizing the effects of LPS and thereby the response to it;
and b) by limiting the extent of the inflammatory
response to infection, thus compromising defenses
against the infecting pathogen. The basis for these differ-
ences and their significance remain to be determined. We
have shown in previously published work [12] that the
clinical course of WT and SP-A-/- mice differs signifi-
cantly in the pneumonia model, with the SP-A-/- mice
being more susceptible.
We speculate that SP-A functions indirectly as a regula-
tor of lung host defense function, possibly via the alveolar
macrophage, resulting in lower baseline levels of many
DEF proteins in SP-A-/- mice. These deficits in the SP-A-
/- mice appear to be rapidly compensated for with the
induction of infection, but without a corresponding
improvement in clinical status (i.e. survival). This lack of
improvement indicates that the direct effects of SP-A on
host defense against K. pneumoniae (i.e. enhancement of
phagocytosis [12,15] or bacterial killing) may be more
Figure 3 Network analysis of BAL proteome changes under baseline conditions. Changes in levels of expression between WT and SP-A-/- mice 
under baseline conditions and at 4 hr after infection (Figure 4) were analyzed using the Ingenuity Pathway program focusing on pathways related to 
lung disease (shown as Function (Fx) in olive green squares). Proteins undergoing significant changes are indicated in bold. Changing proteins that 
were not included in the pathway are shown in the inset in the lower right corner. The relationship between symbol color and relative levels of ex-
pression is shown in the upper left corner. Unshaded proteins in the pathway were not identified in our gels. The proteins included in the analysis and 
the Ingenuity abbreviation are listed below (see also Table 1): Cytosolic malate dehydrogenase: MDH1; Ferritin light chain 1: FTL; Gamma-actin: ACTG1; 
Gelsolin: GSN; Glutathione S-transferase, alpha 3: GSTA3; Glutathione S-transferase, alpha 4: GSTA4; Glutathione S-transferase, mu 1: GSTM5; Glutathi-
one S-transferase, omega 1: GSTO1; Glutathione S-transferase, Ya chain (GST class-alpha): GSTA5; Haptoglobin: HP; Hemoglobin subunit alpha: HBA2; 
Isocitrate dehydrogenase: IDH1; Keratin complex 1, acidic, gene 10: KRT10; Kpnb1 protein b: KPNB1; Lactate dehydrogenase 2, B chain: LDHB; 
Lysozyme 2:; LYZ; Murinoglobulin-1 precursor: MUG1; Myosin heavy chain IIB: MYH4; Peroxiredoxin 1: PRDX1; Peroxiredoxin 6: PRDX6; Pregnancy zone 
protein: PZP; Prothrombin precursor: F2; Pulmonary surfactant associated protein A precursor: SFTPA1; Rho GDP dissociation inhibitor (GDI) alpha: AR-
HGDIA; SEC14-like 3: SEC14L3; Selenium binding protein 1: SELENBP1; Toll-like receptor 13 precursor: TLR13; Transferrin: TF; Tyrosine-3-monooxyge-
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infection.
Conclusion
In summary, this proteomic comparison of BAL proteins
in WT and SP-A-/- mice under normal conditions and
after infection with K. pneumoniae provide us with the
following information. 1) Proteins involved in the regula-
tion of host defense and redox balance are reduced in the
SP-A-/- mice under baseline conditions. Prior evidence
that the alveolar macrophages of SP-A-/- mice are dys-
functional or hypoactive [12] lead us to speculate that
reduced levels of regulatory molecules produced by these
macrophages may be responsible for these lower levels of
expression of DEF and RED proteins. 2) Although SP-A-/
- mice have reduced levels of DEF and RED proteins
under baseline conditions, when faced with an appropri-
ate stimulus (in this case infection with K. pneumoniae)
they respond vigorously by increasing the levels of many
of the molecules that had been at low levels. 3) Despite
baseline differences between mouse strains, the pattern
(but not necessarily the magnitude) of changes in protein
expression in response to infection in many respects is
similar in both strains. 4) However, there are a few con-
spicuous differences in the regulatory patterns of some
proteins after infection. These observations demonstrate
that SP-A may directly or indirectly alter the regulation of
a number of proteins involved in host defense.
Based on this study and previously published work
[12,15] we propose a model in which SP-A regulates host
defense function by both indirect and direct mechanisms.
The indirect effects, as documented in this study, com-
prise a broad-based regulation of levels of expression of a
number of BAL proteins important for innate immunity
and host defense function. In the K. pneumoniae model
employed here these deficits were rapidly reversed by the
infectious challenge, perhaps indicating overlap in the
regulation of various mediators by SP-A and bacterial
Figure 4 Network analysis of BAL proteome changes at 4 hours after infection. Changes in levels of expression between WT and SP-A-/- mice 
under baseline conditions (Figure 3) and at 4 hr after infection (Figure 4) were analyzed using the Ingenuity Pathway program. A description of the 
figure and the abbreviations used are the same as those in the legend for Figure 3.
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the SP-A-/- mice have increased mortality and morbidity
when compared to WT mice [12,15], suggesting that, at
least with respect to K. pneumoniae, direct effects of SP-
A on host defense function (i.e. enhancement of phagocy-
tosis) are more important than the pleiotropic indirect
effects on the BAL proteome.
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